September 24, 2024
TOPLINE: The prevalence of obesity among US adults is 40.3%, and the prevalence of severe obesity is 9.4%, according to the latest data (2021-2023) from the […]
September 23, 2024
TOPLINE: The US Food and Drug Administration (FDA) has issued 510(k) clearance to See-Mode Technologies for their AI-based thyroid ultrasound analysis and reporting software. While various […]
September 23, 2024
TOPLINE: Metabolic/bariatric surgery (MBS) reduces thyroid-stimulating hormone (TSH), free triiodothyronine (fT3) levels, and thyroid hormone resistance indices in patients with obesity, changes strongly correlated with improvement […]
September 23, 2024
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and […]
September 20, 2024
TOPLINE: Diabetes and prediabetes are associated with accelerated brain aging with brain age gaps of 2.29 and 0.50 years, respectively. This association is more pronounced in […]
September 20, 2024
Patients with obesity or type 2 diabetes (T2D) who stuck with their medication for a year lost more weight with semaglutide than with liraglutide, a new […]
September 20, 2024
TOPLINE: Higher body mass index (BMI) in both partners is linked to lower fecundability and increased subfertility. Overweight and obesity in women are associated with higher […]
September 20, 2024
The government of Canada recently took the “next step” in addressing per- and polyfluoroalkyl substances (PFAS) with an updated Draft State of PFAS Report and Revised […]
September 19, 2024
(Reuters) -The European Medicines Agency backed the use of Novo Nordisk’s popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker […]